Filing Flows › Lucid Diagnostics (LUCD) › Q2 2026 › vs Q1 2026
Lucid Diagnostics (LUCD) Q2 2026 vs Q1 2026 (quarter over quarter)
Lucid Diagnostics's revenue rose $218K (+17%) from $1.3M in Q1 2026 to $1.5M in Q2 2026.
Lucid Diagnostics, Q2 2026: revenue $1.5M (+27% year over year), operating margin -868.5%, net loss $11.7M, operating cash flow −$11.3M. The chart draws each line against Q1 2026, the increases inside each band.
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $1.5M | $1.3M | $218K | +17% |
| Other income, net | $1.1M | −$1.8M | $2.9M | — |
| Net loss | $11.7M | $13.9M | −$2.2M | -16% |
| Costs & expenses | $14.3M | $15.2M | −$890K | -6% |
| Operating costs | $14.3M | $13.4M | $905K | +7% |
| Cost of revenue | $1.4M | $1.6M | −$180K | -11% |
| Research & development | $1.2M | $1.2M | −$14K | -1% |
| Sales & marketing | $5.8M | $5.0M | $774K | +15% |
| General & admin | $5.8M | $5.4M | $325K | +6% |
| Other operating costs | $105K | $105K | $0 | 0% |
| Operating cash sources | $13.2M | $13.7M | −$519K | -4% |
| Depreciation & amortization | $224K | $222K | $2K | +0.9% |
| Share-based compensation | $1.7M | $1.4M | $283K | +20% |
| Cash used in operations | $11.3M | $12.1M | −$804K | -7% |
| Net loss absorbed | $11.7M | $13.9M | −$2.2M | -16% |
| Working capital & other | $1.5M | −$175K | $1.7M | — |
Questions
How much did Lucid Diagnostics's revenue grow quarter over quarter in Q2 2026?
Lucid Diagnostics's revenue rose $218K (+17%) from $1.3M in Q1 2026 to $1.5M in Q2 2026.